Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2011
11/17/2011WO2011141474A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
11/17/2011WO2011141326A1 Substituted heterocyclyl benzyl pyrazoles, and use thereof
11/17/2011WO2011141325A1 Hydroxyalkyl benzyl pyrazoles, and use thereof for the treatment of hyperproliferative and angiogenic diseases
11/17/2011WO2011140936A1 5,5-disubstituted-2-imino-pyrrolidine derivatives, preparation methods and pharmaceutical uses thereof
11/17/2011WO2011140599A1 Chemical compound arrays useful for detecting bacterial peptides
11/17/2011US20110282070 Benzoylpyrazole compounds and herbicides containing them
11/17/2011US20110282056 Protein kinase inhibitors and use thereof
11/17/2011US20110281910 Hepatitis C Virus Inhibitors
11/17/2011US20110281899 Methods of preventing and treating low bone mass diseases
11/17/2011US20110281881 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
11/17/2011US20110281876 Therapeutic agents useful for treating pain
11/17/2011US20110281875 Inhibitors of IAP
11/17/2011US20110281873 Pyrimidine Compounds and Methods of Making and Using Same
11/17/2011US20110281872 Compositions and methods for the prevention and treatment of cancer
11/17/2011US20110281871 Taar1 ligands
11/17/2011US20110281870 Novel substituted octahydrocyclopenta[c]pyrrol-4-amines as calcium channel blockers
11/17/2011US20110281869 Tetrahydroisoquinolines as antimalarial agents
11/17/2011US20110281868 Indazole inhibitors of kinase
11/17/2011US20110281861 Thiazopyrimidinones and uses thereof
11/17/2011US20110281859 Novel heterocyclic compounds as metap-2 inhibitors
11/17/2011US20110281854 Morpholine compounds
11/17/2011US20110281851 Biphenyl compounds useful as muscarinic receptor antagonists
11/17/2011US20110281848 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/17/2011US20110281843 Substituted indazole derivatives active as kinase inhibitors
11/17/2011US20110281842 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
11/17/2011US20110281841 Kinase Inhibitors
11/17/2011US20110281838 5-alkynyl-pyrimidines
11/17/2011US20110281837 3-substituted-6-aryl pyridines
11/17/2011US20110281821 Modulators of Mitotic Kinases
11/17/2011US20110280808 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
11/17/2011US20110280804 Highly selective sigma receptor radioligands
11/17/2011CA2799154A1 Indazole inhibitors of kinase
11/17/2011CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
11/17/2011CA2799020A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
11/17/2011CA2798831A1 Morpholine compounds as mineralocorticoid receptor antagonists
11/17/2011CA2798763A1 Compounds useful as inhibitors of atr kinase
11/17/2011CA2798760A1 2-aminopyridine derivatives useful as inhibitors of atr kinase
11/17/2011CA2798490A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
11/17/2011CA2798375A1 Substituted heterocyclyl benzyl pyrazoles, and use thereof
11/16/2011EP2385939A1 Dihydropyridone amides as p2x7 modulators
11/16/2011EP2385938A1 Sulfonamide derivatives
11/16/2011EP2285800B1 Quinoline or isoquinoline substituted p2x7 antagonists
11/16/2011EP2231679B1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
11/16/2011EP2142533B1 Imidazolidinone derivatives
11/16/2011EP2086959B1 Substituted 2-imidazoles as modulators of the trace amine associated receptors
11/16/2011EP1899325B1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase
11/16/2011EP1746999B1 4-phenylamino-quinazolin-6-yl-amides
11/16/2011EP1727794B1 Novel benzyl(idene)-lactam derivatives
11/16/2011CN1938291B Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
11/16/2011CN102245602A Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
11/16/2011CN102245600A Pyrrolone melanin concentrating hormone receptor-1 antagonists
11/16/2011CN102245599A New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
11/16/2011CN102245183A New compounds v
11/16/2011CN102245181A Heterocyclic benzimidazoles as TRPM8 modulators
11/16/2011CN102241970A Near infrared fluorescent probe for detecting zinc ions in water phase and preparation method thereof
11/16/2011CN102241642A Compound, composition, retardation plate, elliptically-polarizing plate and liquid-crystal display device
11/16/2011CN102241636A Derivative of ligustrazine
11/16/2011CN102241621A 5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof
11/16/2011CN101781243B Pharmaceutical intermediate, preparation method thereof and method for preparing iloperidone by pharmaceutical intermediate
11/15/2011US8058457 Star-shaped oligothiophene-arylene derivatives and organic thin film transistors using the same
11/15/2011US8058445 Substituted pyridinecarboxamides for the treatment of cancer
11/15/2011US8058444 Heterocycle-substituted pyridine derivative's salt or crystal thereof
11/15/2011US8058441 For control fertility, contraception, breast cancer, prostate cancer and endometriosis; modulating activity of the follicle stimulating hormone (FSH) receptor; 1-Acetyl-6-(tert-butoxycarbonyl)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline
11/15/2011US8058427 Coumarin compounds and their use for treating cancer
11/15/2011US8058299 Diacylglycerol acyltransferase inhibitors
11/15/2011US8058291 Methods and compositions for the treatment of CNS-related conditions
11/15/2011US8058288 Amido compounds and their use as pharmaceuticals
11/15/2011US8058276 Heterobicyclic carboxamides as inhibitors for kinases
11/15/2011US8058271 Selective inhibitors of rock protein kinase and uses thereof
11/15/2011US8058269 Oxindole derivatives
11/15/2011US8058045 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
11/15/2011CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011CA2477212C Novel arylamidine derivative or salt thereof
11/15/2011CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/10/2011WO2011140190A1 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011WO2011140160A1 Bicyclic heteroaryl compounds as gpr119 modulators
11/10/2011WO2011139107A2 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and phamaceutical composition comprising the same
11/10/2011WO2011138916A1 Polycyclic compound
11/10/2011WO2011138657A1 Aryl substituted olefinic compounds as pde10a inhibitors
11/10/2011WO2011138427A2 Pyridazinones as gpr119 agonists
11/10/2011WO2011138293A1 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
11/10/2011WO2011107530A3 Inhibitors of glutaminyl cyclase
11/10/2011US20110275805 Method for preparing linezolid and intermediates thereof
11/10/2011US20110275804 Process for the preparation of piperazine compounds and hydrochloride salts thereof
11/10/2011US20110275803 Process for synthesizing oxidized lactam compounds
11/10/2011US20110275797 N-acyl anthranilic acid derivative or salt thereof
11/10/2011US20110275762 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
11/10/2011US20110275678 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics
11/10/2011US20110275677 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
11/10/2011US20110275673 Inhibitors of sphingosine kinase 1
11/10/2011US20110275639 C5aR ANTAGONISTS
11/10/2011US20110275638 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011US20110275637 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011US20110275636 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011US20110275635 Small molecule inhibitors of nads, namnat, and nmnat
11/10/2011US20110275633 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
11/10/2011US20110275631 Heteroaryl Substituted Indole Compounds Useful as MMP-13 Inhibitors
11/10/2011US20110275630 Isoindolinone kinase inhibitors
11/10/2011US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011US20110275628 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity